The Dividend Dogs Rule The "dog" moniker was earned by stocks exhibiting three traits: (1) paying reliable, repeating dividends, (2) their prices fell to where and (3) yield (dividend/price) grew higher than their peers. Thus, the ... Seeking Alpha, 3 weeks ago
NASDAQ Index Gets Overbought At Year-End - Seeking Alpha, 3 weeks ago
2 images for "amgen rank"
T. Rowe Price Small-Cap Stock (OTCFX) a Zacks Rank #2 (Buy) seeks long-term capital growth by investing primarily in stocks of small companies. OTCFX invests at least 80% of net assets in stocks and equity related securities of small companies. A ...Yahoo! Finance, 1 month ago
More from: Zacks.com, Zacks.com...and 1 other sources
American Funds American Mutual A (AMRMX) a Zacks Rank #1 (Strong Buy) seeks to provide for the balanced accomplishment of three objectives current income, capital growth and conservation of principal. AMRMX invests primarily in common stocks, ...Yahoo! Finance, 1 month ago American Funds American Mutual R4 Fund (RMFEX) in Focus Zacks.com, 1 month ago
American Funds AMCAP A (AMCPX) a Zacks Rank #1 (Strong Buy) was incepted in May 1967 and is managed by Capital Research and Management Company. The objective of AEPGX is to provide long-term growth of capital. AEPGX invests in established growth ...Yahoo! Finance, 1 month ago
For Immediate Release Chicago, IL January 05, 2017 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.Zacks.com, 2 weeks ago
Novartis AG NVS and partner Amgen Inc. AMGN announced positive top-line data from the second pivotal phase III study (STRIVE) on their calcitonin gene-related peptide (CGRP) receptor, AMG 334 (erenumab), for the prevention of episodic migraine. The ...Yahoo! Finance, 2 months ago
More from: , Yahoo! Canada...and 2 other sources
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when ...Nasdaq, 1 day ago
Amgen Inc. AMGN announced that data from three phase III studies on its pipeline candidate, Parsabiv (etelcalcetide), were published in the Journal of the American Medical Association (JAMA). The studies evaluated Parsabiv in 1706 adult patients ...Yahoo! Canada, 1 week ago
Amgen Inc. AMGN announced a new six-year sourcing and supply agreement with DaVita Inc. DVA to supply Epogen and Aranesp to meet the latter's requirements. Denver, CO-based DaVita provides kidney dialysis services to patients suffering from chronic ...Zacks.com, 1 week ago
Amgen Inc. AMGN received encouraging news when a Delaware district court upheld its patents for PCSK9 inhibitor, Repatha, against Sanofi SNY and Regeneron Pharmaceuticals, Inc. REGN . Amgen's share rose close to 4% in after-hours trading on ...Zacks.com, 2 weeks ago
More from: , Nasdaq...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!